Prospective Study of Treatment with Ensitrelvir for COVID-19 in Patients Undergoing Hemodialysis (PROTECT-HD)

Mineaki Kitamura; Takahiro Takazono; Naoki Hosogaya; Shimpei Morimoto; Masahiro Kinoshita; Eriko Hamada; Ryosuke Shimizu; Shogo Miyazawa; Shintaro Tanaka; Tomoya Nishino; Hiroshi Mukae

doi:10.1007/s40121-026-01327-2

April 1, 2026Infectious Diseases and TherapyOpen Access

Prospective Study of Treatment with Ensitrelvir for COVID-19 in Patients Undergoing Hemodialysis (PROTECT-HD)

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the efficacy of ensitrelvir in treating COVID-19 among patients undergoing hemodialysis.
Conducted a prospective study design
Involved patients receiving hemodialysis
Administered ensitrelvir treatment
Monitored clinical outcomes
Found improvements in COVID-19 symptoms
Reported fewer complications related to the virus

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Prospective study investigates ensitrelvir’s impact on COVID-19 outcomes in hemodialysis patients, indicating potential benefits for this vulnerable group.

Abstract

Japan Registry of Clinical Trials ID: jRCTs071240069.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kitamura et al. (2026) studied this question.

synapsesocial.com/papers/69cf5d1f5a333a821460ab41 https://doi.org/10.1007/s40121-026-01327-2

View Full Paper

Ask AI

Bookmark

Share

Prospective Study of Treatment with Ensitrelvir for COVID-19 in Patients Undergoing Hemodialysis (PROTECT-HD)

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Prospective Study of Treatment with Ensitrelvir for COVID-19 in Patients Undergoing Hemodialysis (PROTECT-HD)

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading